Log in or Sign up for Free to view tailored content for your specialty!
Alzheimer’s Disease/Dementia News
Personalized TMS leads to 44% slowing of Alzheimer’s progression at 1 year
Treatment with non-invasive, personalized repetitive transcranial magnetic stimulation in those with mild to moderate Alzheimer’s resulted in a 44% slowing of disease progression at 52 weeks, according to the manufacturer.
Cardiovascular health in middle age strongly associated with brain health in later years
Cardiovascular health of middle-aged adults was significantly associated with the risk of poor brain health later in life, according to a study published in Neurology.
Log in or Sign up for Free to view tailored content for your specialty!
Semaglutide linked to reduced risk for Alzheimer’s in patients with diabetes
In patients with type 2 diabetes, semaglutide was associated with a significantly lower risk for an Alzheimer’s disease diagnosis within 3 years compared with other diabetes medications, according to a study published in Alzheimer’s & Dementia.
VIDEO: Sleep physiology and risk for Alzheimer’s, obesity and CV events
BOSTON — In this Healio video exclusive, Virend K. Somers, MD, PhD, discusses his presentation at the Cardiometabolic Health Congress, “Sleep Disorders and Cardiometabolic Health.”
Analysis of Alzheimer’s pathology in brain cells finds deterioration in two stages
A genetic analysis of postmortem brains from individuals in various stages of Alzheimer’s disease revealed two distinct phases of cell deterioration, according to research published in Nature Neuroscience.
NIH awards $3.3 million for oral disease-modifying Alzheimer’s, Parkinson’s therapeutic
The NIH has awarded a $3.3 million grant to advance a novel, oral silent allosteric modulator intended to treat Alzheimer’s and Parkinson’s diseases, according to the manufacturer.
Dementia more frequently diagnosed in older adults within a year of fall-related injury
Falling was associated with an increased risk for a diagnosis of Alzheimer’s disease or other dementias in older adults, according to a recent analysis in JAMA Network Open.
The promise of anti-amyloid therapies: A new era in Alzheimer’s treatment
The world is facing an impending tsunami as the number of people developing Alzheimer’s disease continues to grow.
Tiziana Life Sciences receives $4M from NIH to advance intranasal Alzheimer’s therapy
A New York-based biotechnology company has received a $4 million grant from the NIH’s National Institute on Aging to advance a novel intranasal therapeutic to treat Alzheimer’s disease, according to a press release from the manufacturer.
Study: No clear association between pet ownership and brain, heart health
ORLANDO, Fla. — An analysis of a large cohort of individuals enrolled in a continuous, multinational survey found no clear associations between brain and heart health and pet ownership, according to a poster.
-
Headline News
Q&A: ‘We have to be worried’ about decline in measles vaccination
November 19, 20244 min read -
Headline News
Physicians encouraged to ‘embrace’ technology in practice management
November 19, 20245 min read -
Headline News
Artificial neural network has ‘excellent’ performance in predicting COPD exacerbations
November 20, 20242 min read
-
Headline News
Q&A: ‘We have to be worried’ about decline in measles vaccination
November 19, 20244 min read -
Headline News
Physicians encouraged to ‘embrace’ technology in practice management
November 19, 20245 min read -
Headline News
Artificial neural network has ‘excellent’ performance in predicting COPD exacerbations
November 20, 20242 min read